Nurse Practitioner, Primary Care · Miami, FL
NPI
1356733877
Since 2015
Specialty
Nurse Practitioner, Primary Care
Code 363LP2300X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
2995 SW 110th Ave
Miami, FL, 33165
Phone (786) 239-2051
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$342K
14,086 prescriptions
Company payments, 2025
$1,860
From 4 companies
Medicare prescription drug claims, 2024
In 2024, the drug Milko R Moriyon prescribed most often to Medicare patients was Trazodone Hcl, with 1,425 prescriptions and refills. In total Milko R Moriyon wrote 14,086 Medicare prescriptions that cost $342K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-08-19.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Trazodone Hcl Generic | 1,425 | 1,657 | 272 | $5,648 |
| Escitalopram Oxalate Generic | 1,290 | 1,554 | 244 | $6,095 |
| Alprazolam Generic | 1,190 | 1,194 | 197 | $3,500 |
| Sertraline Hcl Generic | 1,152 | 1,355 | 218 | $3,708 |
| Mirtazapine Generic | 928 | 1,112 | 184 | $20K |
| Quetiapine Fumarate Generic | 854 | 1,120 | 150 | $13K |
| Clonazepam Generic | 836 | 841 | 122 | $5,084 |
| Temazepam Generic | 598 | 598 | 113 | $3,183 |
| Chlordiazepoxide Hcl Generic | 498 | 498 | 87 | $4,024 |
| Donepezil Hcl Generic | 495 | 603 | 118 | $1,349 |
| Lorazepam Generic | 481 | 487 | 73 | $2,999 |
| Memantine Hcl Er Memantine Hcl | 431 | 453 | 69 | $101K |
| Buspirone Hcl Generic | 384 | 407 | 89 | $5,082 |
| Citalopram Hbr Citalopram Hydrobromide | 320 | 410 | 63 | $659 |
| Memantine Hcl Generic | 297 | 474 | 103 | $8,920 |
Brand drugs: - claims; generic drugs: 13,986 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Milko R Moriyon $1,860 ($1,860 in general payments such as food, travel and fees) from 4 companies. The largest payer was Neurocrine BioSciences, Inc. with $1,753.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.